J&J device chief on company split, omicron surge, robotic surgery

Procedure volumes have been one of the most-watched topics for medtechs in 2021, particularly for companies like Johnson & Johnson, Stryker and Boston Scientific, which are more dependent on surgeries to drive revenues.
After the industry looked like it was rebounding…
Source: www.healthcaredive.com and Read More